In cSCC, mutant p53 (mutp53) promotes tumor progression by enhancing Smad2/3 transcriptional activity, thereby inducing the expression of TGF-β1-responsive genes such as PAI-1, connective tissue growth factor (CTGF), and IL-6 [31]. This evidence concerns the gene CCN2 and neoplasm.